Trial Profile
A Randomized, Double-blind, Single-Center Trial of Alvimopan (Entereg) Versus Placebo in Patients Undergoing Radical Cystectomy and Urinary Diversion on an Enhanced Recovery After Surgery ERAS Protocol
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Oct 2023
Price :
$35
*
At a glance
- Drugs Alvimopan (Primary)
- Indications Postoperative ileus
- Focus Therapeutic Use
- 26 Sep 2023 Planned End Date changed from 1 Dec 2021 to 1 Jun 2024.
- 26 Sep 2023 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2023.
- 19 Jul 2021 Planned End Date changed from 1 Jul 2021 to 1 Dec 2021.